{"disease":{"id":"haemophilia-a","name":"haemophilia a"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03276130","title":"Management of Health-Related QoL Impairment, Including Pain, Depression and Anxiety, in People With Haemophilia A and B","phase":"","overall_status":"COMPLETED","enrollment_count":2300,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false},{"nct_id":"NCT01322620","title":"Survey Evaluating the Psychosocial Effects of Living With Haemophilia","phase":"","overall_status":"COMPLETED","enrollment_count":1236,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06574984","title":"Study for Turoctocog Alfa Treatment Regimen in Iraqi Haemophilia A Patients","phase":"","overall_status":"RECRUITING","enrollment_count":900,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03660774","title":"A Study of the Impact of Hemophilia and Its Treatment on Brain Development, Thinking and Behaviour in Children With Hemophilia","phase":"","overall_status":"COMPLETED","enrollment_count":563,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT05685238","title":"A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A (FRONTIER 4)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":451,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03619863","title":"ATHN 7: Hemophilia Natural History Study","phase":"","overall_status":"COMPLETED","enrollment_count":395,"lead_sponsor_name":"American Thrombosis and Hemostasis Network","has_results":false},{"nct_id":"NCT01579955","title":"Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":321,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03430154","title":"Awareness, Care, and Treatment In Obesity Management of Patients With Hemophilia (ACTION) to Inform Hemophilia Obesity Patient Empowerment (HOPE)","phase":"","overall_status":"COMPLETED","enrollment_count":317,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT05053139","title":"A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":281,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT04204408","title":"A Research Study Investigating Mim8 in People With Haemophilia A","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":275,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT04524481","title":"Osteoporosis and Haemophilia","phase":"","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"PD Dr. Andreas Strauß","has_results":false},{"nct_id":"NCT03818529","title":"ATHN 8: Previously Untreated Patients (PUPs) Matter Study","phase":"","overall_status":"COMPLETED","enrollment_count":237,"lead_sponsor_name":"American Thrombosis and Hemostasis Network","has_results":false},{"nct_id":"NCT03741881","title":"A Study Following People With Haemophilia A and B, With or Without Inhibitors, When on Usual Treatment (Explorer™6)","phase":"","overall_status":"COMPLETED","enrollment_count":231,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT00984126","title":"Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":214,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT05681845","title":"A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and Cartridge","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":205,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT03055611","title":"A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B","phase":"","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Swedish Orphan Biovitrum","has_results":false},{"nct_id":"NCT01480180","title":"Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT03528551","title":"A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT04082429","title":"Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":156,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT05135559","title":"A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":153,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT04083781","title":"Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With Inhibitors","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":134,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT02137850","title":"Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":124,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT04165135","title":"An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":103,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT05621746","title":"An Observational Research Study of the Health of Joints in People With Haemophilia Taking the Medicine Esperoct","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT06649630","title":"A Study Looking at How Different Doses of Study Medicine (Inno8) Works in the Body of Healthy Men","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":95,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01311648","title":"BAY81-8973 Pediatric Safety and Efficacy Trial","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":94,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT01579968","title":"Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery","phase":"","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT07238816","title":"A Research Study Looking at How Food Intake Affects Inno8 in the Body of Healthy People","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT05306418","title":"A Research Study Looking at Mim8 in Children With Haemophilia A With or Without Inhibitors","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02035384","title":"Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A","phase":"","overall_status":"COMPLETED","enrollment_count":69,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01731600","title":"A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT02938585","title":"Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT05127473","title":"A Research Study of How a New Medicine NNC0365-3769 (Mim8) Works in the Body of Healthy People","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT04675541","title":"Register of Patients With haEmophilia A tReated With Afstyla®","phase":"","overall_status":"COMPLETED","enrollment_count":62,"lead_sponsor_name":"CSL Behring","has_results":false},{"nct_id":"NCT05878938","title":"A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT04574076","title":"A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":60,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT01493778","title":"Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT03449342","title":"Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT01228669","title":"Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02994407","title":"Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT04682145","title":"Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":50,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02781766","title":"TGA (Thrombin Generation Assay) and Prophylaxis in Haemophilia","phase":"NA","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT06809972","title":"Synovial Proliferation on Routine Ultrasound: Active or Inactive?","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":46,"lead_sponsor_name":"Van Creveldkliniek","has_results":false},{"nct_id":"NCT02207218","title":"To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false},{"nct_id":"NCT02229331","title":"Biomechanical Determinants and Patterns Associated to the Pathophysiological Cascade of Ankle Arthropathy in Children With Haemophilia: Non-invasive In-vivo Measurement of Foot Joints in Children With Haemophilia During Gait.","phase":"","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT07437404","title":"Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Sinocelltech Ltd.","has_results":false},{"nct_id":"NCT01489111","title":"Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT03196297","title":"A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT05082116","title":"Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Novo Nordisk A/S","has_results":true},{"nct_id":"NCT02941354","title":"Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Novo Nordisk A/S","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}